On July 15, 2025, the Centers for Medicare & Medicaid Services (CMS) released an Audit and Enforcement Report summarizing its annual Medicare Advantage (Part C) and Prescription Drug (Part D) program ...

WASHINGTON — The Centers for Medicare & Medicaid Services and U.S. Department of Health and Human Services should take action to increase the participation of care providers for mental health and ...

On September 24, 2024, OIG released a report recommending that CMS exercise additional oversight of remote patient monitoring (RPM) services provided to Medicare beneficiaries. Medicare reimburses RPM ...

The Centers for Medicare & Medicaid Services (CMS) is expecting outlays on Alzheimer's disease drug Leqembi that far outpace the drugmaker's estimates next year. In a document (PDF) recapping a ...

A major consumer advocacy group is urging federal regulators to use newly expanded nursing home ownership data to block owners associated with other poorly performing facilities from obtaining ...

In response to the report, CMS concluded that dermatologists are complying with modifier 25 coding rules and the agency will not impose any additional regulations in this area.

A review by the Office of Inspector General has found little improvement in CMS’ reporting of adverse actions for providers since the OIG made a recommendation in 2010 to improve the reporting process ...